Updated December 30, 2012
Updated December 16, 2012
Updated December 9, 2012
Updated December 2, 2012
Updated November 25, 2012
Updated November 18, 2012
Gilead ’s Complera® Non-Inferior to Atripla® Among Treatment-Naïve HIV Patients
Half of HIV-positive gay men disagree that HIV treatment makes you less infectious
Lack of understanding of treatment benefits discourage women with HIV having children
Telaprevir is safe and effective for HIV/HCV co-infected people
Reducing ribavirin and adding EPO are both good anaemia management
Updated November 11, 2012
Updated October 14, 2012
Updated October 7, 2012
From
today, HIV treatment is free for all who need it in
Ukraine parliament votes to outlaw "promotion of homosexuality"
Updated September 30, 2012
Don't rule out IFN/ribavirin for HIV patients with hep C cirrhosis: study
Local bio-techs doing significant research on cure for HIV and AIDS
Updated September 23, 2012
Experts divided whether to give HIV positive children preventive TB treatment
Dr. Jerome Horwitz, Developer Of HIV Drug AZT, Passes Away At 93
Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS
Updated September 16, 2012
Symptom screen frequently misses HIV in children and delays treatment
Long-acting fusion inhibitor albuvirtide looks promising in early studies
Bacterial translocation is associated with more severe liver fibrosis in HIV/hepatitis C-co-infected people
Updated September 9, 2012
Updated August 26, 2012
Updated August 19, 2012
Updated August 12, 2012
Updated August 5, 2012
HIV-Infected T Cells Help Transport the Virus Throughout the Body
Gilead signs deals with Indian companies for low-cost HIV drug
Updated July 15, 2012
Updated June 24, 2012
Updated June 10, 2012
Updated June 4, 2012
Gay men and young heterosexual adults in England had high rates of STIs
Report examines role of HIV partner notification and online technology
Innovative biochip holds promise for cheap, portable HIV testing
Updated May 27, 2012
Anti-HIV Product For Both Vagina And Rectum - Tenofovir Vaginal Gel
CD4 cell count below 350 associated with a key marker of cardiovascular risk
Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men
Reactions to HIV drug have autoimmune cause, reports AIDS journal
Updated May 20, 2012
Updated May 13, 2012
Burma suffering from huge shortfall in HIV and Aids drugs, warn doctors
Updated May 7, 2012
Updated April 22, 2012
ARVs and HIV Prevention: Controversies, Conflicts and Consensus
Telaprevir and boceprevir show serious side-effects in hepatitis C patients
Updated April 1, 2012
New
Cognitive function improves through the first year of HIV therapy
Updated March 25, 2012
Updated March 18, 2012
Updated February 12, 2012
Updated February 5, 2012
Isentress, Intelence, Prezista Regimen Goes the Distance for HIV Treatment Veterans
Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use
Updated January 29, 2012
Updated January 15, 2012
Updated January 8, 2012